Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and Cyclophosphamide - Concepedia

Concepedia

Publication | Closed Access

Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and Cyclophosphamide

74

Citations

30

References

2003

Year

Paola Papaldo, Massimo Lopez, Enrico Cortesi, Eugenio Cammilluzzi, Mauro Antimi, E. Terzoli, Giuseppe Lepidini, Patrizia Vici, Carlo Barone, G. Ferretti,

Journal of Clinical Oncology

Abstract

EC is active and well tolerated in patients with early breast cancer. The addition of LND or G-CSF does not improve DFS or OS.

References

	Year	Citations

Page 1